Latest filing published 11 May 2017 for Novelion Therapeutics Inc..
No signal scores available.
All filings by Gregory Perry on record concern Novelion Therapeutics Inc. Over a trading history stretching from 29 November 2016 to 9 May 2017, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 11 May 2017: a transaction, in Novelion Therapeutics Inc. The median gap between a trade and its publication by SEDI is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations